These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 23867982)
21. Cognitive functioning during long-term tamoxifen treatment in postmenopausal women with breast cancer. Boele FW; Schilder CM; de Roode ML; Deijen JB; Schagen SB Menopause; 2015 Jan; 22(1):17-25. PubMed ID: 24977455 [TBL] [Abstract][Full Text] [Related]
22. Scopolamine induced deficits in a battery of rat cognitive tests: comparisons of sensitivity and specificity. Hodges DB; Lindner MD; Hogan JB; Jones KM; Markus EJ Behav Pharmacol; 2009 May; 20(3):237-51. PubMed ID: 19436198 [TBL] [Abstract][Full Text] [Related]
23. Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study. Ancelin ML; Artero S; Portet F; Dupuy AM; Touchon J; Ritchie K BMJ; 2006 Feb; 332(7539):455-9. PubMed ID: 16452102 [TBL] [Abstract][Full Text] [Related]
24. Raloxifene hydrochloride, a selective estrogen receptor modulator: safety assessment of effects on cognitive function and mood in postmenopausal women. Nickelsen T; Lufkin EG; Riggs BL; Cox DA; Crook TH Psychoneuroendocrinology; 1999 Jan; 24(1):115-28. PubMed ID: 10098223 [TBL] [Abstract][Full Text] [Related]
25. Tamoxifen in postmenopausal women a safety perspective. Robinson E; Kimmick GG; Muss HB Drugs Aging; 1996 May; 8(5):329-37. PubMed ID: 8935395 [TBL] [Abstract][Full Text] [Related]
26. Tamoxifen disrupts consolidation and retrieval of morphine-associated contextual memory in male mice: interaction with estradiol. Esmaeili B; Basseda Z; Gholizadeh S; Javadi Paydar M; Dehpour AR Psychopharmacology (Berl); 2009 Jun; 204(2):191-201. PubMed ID: 19183965 [TBL] [Abstract][Full Text] [Related]
27. A phase III randomized multicenter trial evaluating cognition in post-menopausal breast cancer patients receiving adjuvant hormonotherapy. Le Rhun E; Delbeuck X; Lefeuvre-Plesse C; Kramar A; Skrobala E; Pasquier F; Bonneterre J Breast Cancer Res Treat; 2015 Aug; 152(3):569-80. PubMed ID: 26160250 [TBL] [Abstract][Full Text] [Related]
28. A randomized trial of the effect of testosterone and estrogen on verbal fluency, verbal memory, and spatial ability in healthy postmenopausal women. Kocoska-Maras L; Zethraeus N; RĂ¥destad AF; Ellingsen T; von Schoultz B; Johannesson M; Hirschberg AL Fertil Steril; 2011 Jan; 95(1):152-7. PubMed ID: 20667535 [TBL] [Abstract][Full Text] [Related]
29. Memory impairments with adjuvant anastrozole versus tamoxifen in women with early-stage breast cancer. Bender CM; Sereika SM; Brufsky AM; Ryan CM; Vogel VG; Rastogi P; Cohen SM; Casillo FE; Berga SL Menopause; 2007; 14(6):995-8. PubMed ID: 17898668 [TBL] [Abstract][Full Text] [Related]
30. The gynecologic effects of lasofoxifene, an estrogen agonist/antagonist, in postmenopausal women. Archer DF Menopause; 2011 Jan; 18(1):6-7. PubMed ID: 21173718 [No Abstract] [Full Text] [Related]
31. Less miscarriage in pregnancy following Tamoxifen treatment of infertile patients with luteal phase dysfunction as compared to clomiphene treatment. Wu CH Early Pregnancy; 1997 Dec; 3(4):301-5. PubMed ID: 10086081 [TBL] [Abstract][Full Text] [Related]
32. Overall Safety of Ospemifene in Postmenopausal Women from Placebo-Controlled Phase 2 and 3 Trials. Simon JA; Altomare C; Cort S; Jiang W; Pinkerton JV J Womens Health (Larchmt); 2018 Jan; 27(1):14-23. PubMed ID: 29064335 [TBL] [Abstract][Full Text] [Related]
34. Modelling dementia: effects of scopolamine on memory and attention. Broks P; Preston GC; Traub M; Poppleton P; Ward C; Stahl SM Neuropsychologia; 1988; 26(5):685-700. PubMed ID: 3211287 [TBL] [Abstract][Full Text] [Related]
35. Tamoxifen: from breast cancer therapy to the design of a postmenopausal prevention maintenance therapy. Jordan VC; MacGregor JI; Tonetti DA Osteoporos Int; 1997; 7 Suppl 1():S52-7. PubMed ID: 9205647 [No Abstract] [Full Text] [Related]
36. Muscarinic and nicotinic receptors synergistically modulate working memory and attention in humans. Ellis JR; Ellis KA; Bartholomeusz CF; Harrison BJ; Wesnes KA; Erskine FF; Vitetta L; Nathan PJ Int J Neuropsychopharmacol; 2006 Apr; 9(2):175-89. PubMed ID: 15877932 [TBL] [Abstract][Full Text] [Related]
37. Effect of estrogen on brain activation patterns in postmenopausal women during working memory tasks. Shaywitz SE; Shaywitz BA; Pugh KR; Fulbright RK; Skudlarski P; Mencl WE; Constable RT; Naftolin F; Palter SF; Marchione KE; Katz L; Shankweiler DP; Fletcher JM; Lacadie C; Keltz M; Gore JC JAMA; 1999 Apr; 281(13):1197-202. PubMed ID: 10199429 [TBL] [Abstract][Full Text] [Related]
38. Cognitive and behavioral effects of cholinergic, dopaminergic, and serotonergic blockade in humans. Vitiello B; Martin A; Hill J; Mack C; Molchan S; Martinez R; Murphy DL; Sunderland T Neuropsychopharmacology; 1997 Jan; 16(1):15-24. PubMed ID: 8981385 [TBL] [Abstract][Full Text] [Related]
39. Adjunctive raloxifene treatment improves attention and memory in men and women with schizophrenia. Weickert TW; Weinberg D; Lenroot R; Catts SV; Wells R; Vercammen A; O'Donnell M; Galletly C; Liu D; Balzan R; Short B; Pellen D; Curtis J; Carr VJ; Kulkarni J; Schofield PR; Weickert CS Mol Psychiatry; 2015 Jun; 20(6):685-94. PubMed ID: 25980345 [TBL] [Abstract][Full Text] [Related]
40. Preliminary assessment of cognitive function in breast cancer patients treated with tamoxifen. Paganini-Hill A; Clark LJ Breast Cancer Res Treat; 2000 Nov; 64(2):165-76. PubMed ID: 11194452 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]